Newswise — HERCULES, Calif.– July 27, 2016 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced the launch of two human recombinant antigens, expanding the company’s portfolio of Critical Raw Materials for the in vitro diagnostics market. These cell culture and recombinant antigens provide Bio-Rad customers with reliable critical assay components for use in lung and ovarian cancer diagnostics.
Bio-Rad’s line of Critical Raw Materials are intermediate and semi-finished goods that are used for re-manufacture into standards, controls, calibrators as well as research into future assay development.
“Bio-Rad is pleased to offer an expanded product line to better support our valued customers,” said Conrad Maurais, Product Manager, Bio-Rad “With the introduction of the cell culture derived SCCA-1 and HE4 antigens we enable customers the opportunity to reduce their dependence upon antigens from human fluids and strengthen the integrity of their supply chain for these critical raw materials."
The New Antigens Include:
• HE4 Antigen: used as an aid in monitoring recurrence or progressive disease in patients with epithelial and endometrial ovarian cancer.
• Squamous Cell Carcinoma Antigen 1 (SCCA-1): used for detecting, staging and monitoring response to therapy in patients with squamous cell carcinoma of the lung.
Bio-Rad is a leading provider of human recombinant antigens with over 25 years of experience providing Critical Raw Materials. For more information, please call 207-615-0571 or visit http://www.qcnet.com/crm/
About Bio-RadBio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs more than 7,800 people worldwide and had revenues exceeding $2 billion in 2015. For more information, please visit www.bio-rad.com.
RSS